City

Houston (1)

Overall Status

Completed (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

M.D. Anderson Cancer Center (1)

Vanderbilt-Ingram Cancer Center (1)

Collaborator

National Cancer Institute (NCI) (2)

Novartis (1)

Intervention

laboratory biomarker analysis (2)

pharmacological study (2)

capecitabine (1)

ribociclib (1)

temozolomide (1)

veliparib (1)

Study Documents

Intervention Type

drug (2)

other (2)

Funder Type

Other (2)

Study Type

Interventional (2)

functional pancreatic neuroendocrine tumor

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced Digestive System Neuroendocrine Tumor, Duodenal Neuroendocrine Tumor G1, Functional Pancreatic Neuroendocrine Tumor

Completed

Has Results

Advanced Digestive System Neuroendocrine Neoplasm
+7 more

Laboratory Biomarker Analysis
+2 more

Houston, Texas

M D Anderson Cancer Center

Oct 8, 2020

Functional Pancreatic Neuroendocrine Tumor, Malignant Somatostatinoma, Merkel Cell Carcinoma Trial (Capecitabine, Temozolomide,

Withdrawn

Functional Pancreatic Neuroendocrine Tumor
+28 more

Capecitabine
+4 more

(no location specified)

Sep 26, 2017